tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CADL Stock Latest News

Candel Therapeutics Advances Gene-Based Prostate Cancer Trial With New Biomarker Update
Company AnnouncementsCandel Therapeutics Advances Gene-Based Prostate Cancer Trial With New Biomarker Update
14d ago
CADL
Candel Therapeutics’ Promising CAN-2409 Program Drives Buy Rating Amid Positive Phase 3 Results and Expert Endorsements
PremiumRatings
Candel Therapeutics’ Promising CAN-2409 Program Drives Buy Rating Amid Positive Phase 3 Results and Expert Endorsements
2M ago
CADL
Candel Therapeutics: Strategic Advancements and Regulatory Progress Support Buy Rating
PremiumRatings
Candel Therapeutics: Strategic Advancements and Regulatory Progress Support Buy Rating
2M ago
CADL
Optimistic Buy Rating for Candel Therapeutics Driven by Promising Pipeline and Strategic Milestones
PremiumRatings
Optimistic Buy Rating for Candel Therapeutics Driven by Promising Pipeline and Strategic Milestones
2M ago
CADL
Candel Therapeutics: Promising Developments Amidst Regulatory and Market Challenges
PremiumRatings
Candel Therapeutics: Promising Developments Amidst Regulatory and Market Challenges
2M ago
CADL
Candel Therapeutics Hosts Virtual R&D Day on Immunotherapy
PremiumCompany AnnouncementsCandel Therapeutics Hosts Virtual R&D Day on Immunotherapy
3M ago
8K
CADL
Candel Therapeutics price target lowered to $24 from $25 at Citi
Premium
The Fly
Candel Therapeutics price target lowered to $24 from $25 at Citi
3M ago
CADL
Candel Therapeutics Advances Cancer Therapies with Strong Q3
Premium
Company Announcements
Candel Therapeutics Advances Cancer Therapies with Strong Q3
3M ago
CADL
Candel Therapeutics reports Q3 EPS (21c) vs (33c) last year
PremiumThe Fly
Candel Therapeutics reports Q3 EPS (21c) vs (33c) last year
3M ago
CADL
Candel Therapeutics announces it will deliver three presentations at SITC
PremiumThe Fly
Candel Therapeutics announces it will deliver three presentations at SITC
4M ago
CADL
Candel initiated with an Overweight at Stephens on differentiated pipeline
PremiumThe Fly
Candel initiated with an Overweight at Stephens on differentiated pipeline
4M ago
CADL
Candel Therapeutics initiated with an Overweight at Stephens
PremiumThe Fly
Candel Therapeutics initiated with an Overweight at Stephens
4M ago
CADL
Positive Buy Rating for Candel Therapeutics Driven by Promising Phase 3 Results of CAN-2409 and Strong Regulatory Prospects
PremiumRatingsPositive Buy Rating for Candel Therapeutics Driven by Promising Phase 3 Results of CAN-2409 and Strong Regulatory Prospects
4M ago
CADL
Candel Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Candel Therapeutics initiated with an Outperform at LifeSci Capital
4M ago
CADL
Candel Therapeutics appoints Pulendran to Candel’s RAB
Premium
The Fly
Candel Therapeutics appoints Pulendran to Candel’s RAB
4M ago
CADL
Candel Therapeutics: Hold Rating Amid Promising Developments and Financial Uncertainty
PremiumRatings
Candel Therapeutics: Hold Rating Amid Promising Developments and Financial Uncertainty
4M ago
CADL
Candel Therapeutics Secures $130M Loan for Trials
PremiumCompany Announcements
Candel Therapeutics Secures $130M Loan for Trials
4M ago
8K
CADL
Candel Therapeutics enters into $130M term loan facility
PremiumThe Fly
Candel Therapeutics enters into $130M term loan facility
4M ago
CADL
TRIN
Candel Therapeutics announces interim data from phase 1b CAN-3110 trial
PremiumThe Fly
Candel Therapeutics announces interim data from phase 1b CAN-3110 trial
4M ago
CADL
Trinity Capital provides $130M in growth capital to Candel Therapeutics
PremiumThe FlyTrinity Capital provides $130M in growth capital to Candel Therapeutics
4M ago
CADL
TRIN
Promising Investment: Candel Therapeutics’ CAN-2409 Shows Efficacy in Prostate Cancer with Potential for Broader Applications
Premium
Ratings
Promising Investment: Candel Therapeutics’ CAN-2409 Shows Efficacy in Prostate Cancer with Potential for Broader Applications
5M ago
CADL
Promising Potential of Candel Therapeutics’ CAN-2409: A Versatile Immunotherapy with Broad Applicability
Premium
Ratings
Promising Potential of Candel Therapeutics’ CAN-2409: A Versatile Immunotherapy with Broad Applicability
5M ago
CADL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >